Literature DB >> 23531448

MicroRNA and cancer chemoprevention.

Bin Yi1, Gary A Piazza, Xiulan Su, Yaguang Xi.   

Abstract

MicroRNAs (miRNA) are a group of naturally occurring, small, noncoding, and single-strand RNA molecules that regulate gene expression at the posttranscriptional and translational levels. By controlling the expression of oncogenic and tumor suppressor proteins, miRNAs are believed to play an important role in pathologic processes associated with malignant progression including tumor cell proliferation, apoptosis, differentiation, angiogenesis, invasion, and metastasis. However, relatively few studies have investigated the influence of chemopreventive agents on miRNA expression and their regulation of target genes. Given the significance of miRNAs in modulating gene expression, such research can provide insight into the pleiotropic biologic effects that chemopreventive agents often display and a deeper understanding of their mechanism of action to inhibit carcinogenesis. In addition, miRNAs can provide useful biomarkers for assessing antineoplastic activity of these agents in preclinical and clinical observations. In this review, we summarize recent publications that highlight a potentially important role of miRNAs in cancer chemoprevention research.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23531448      PMCID: PMC3644360          DOI: 10.1158/1940-6207.CAPR-13-0032

Source DB:  PubMed          Journal:  Cancer Prev Res (Phila)        ISSN: 1940-6215


  95 in total

Review 1.  MicroRNA, nutrition, and cancer prevention.

Authors:  Sharon A Ross; Cindy D Davis
Journal:  Adv Nutr       Date:  2011-11-03       Impact factor: 8.701

2.  MicroRNAs 221/222 and genistein-mediated regulation of ARHI tumor suppressor gene in prostate cancer.

Authors:  Yi Chen; Mohd Saif Zaman; Guoren Deng; Shahana Majid; Shranjot Saini; Jan Liu; Yuichiro Tanaka; Rajvir Dahiya
Journal:  Cancer Prev Res (Phila)       Date:  2010-11-11

3.  Colon cancer chemopreventive activities of pomegranate ellagitannins and urolithins.

Authors:  Sashi G Kasimsetty; Dobroslawa Bialonska; Muntha K Reddy; Guoyi Ma; Shabana I Khan; Daneel Ferreira
Journal:  J Agric Food Chem       Date:  2010-02-24       Impact factor: 5.279

4.  MicroRNA responses to cellular stress.

Authors:  Carmen J Marsit; Karen Eddy; Karl T Kelsey
Journal:  Cancer Res       Date:  2006-11-15       Impact factor: 12.701

5.  Vitamin E dependent microRNA regulation in rat liver.

Authors:  Sonja Gaedicke; Xiangnan Zhang; Constance Schmelzer; Yijia Lou; Frank Doering; Jan Frank; Gerald Rimbach
Journal:  FEBS Lett       Date:  2008-09-24       Impact factor: 4.124

6.  Genistein inhibits growth of human uveal melanoma cells and affects microRNA-27a and target gene expression.

Authors:  Qingmin Sun; Rihong Cong; Hongli Yan; Haijuan Gu; Ying Zeng; Nannan Liu; Jie Chen; Bin Wang
Journal:  Oncol Rep       Date:  2009-09       Impact factor: 3.906

7.  Chemopreventive n-3 polyunsaturated fatty acids reprogram genetic signatures during colon cancer initiation and progression in the rat.

Authors:  Laurie A Davidson; Danh V Nguyen; Regina M Hokanson; Evelyn S Callaway; Robert B Isett; Nancy D Turner; Edward R Dougherty; Naisyin Wang; Joanne R Lupton; Raymond J Carroll; Robert S Chapkin
Journal:  Cancer Res       Date:  2004-09-15       Impact factor: 12.701

8.  Up-regulation of miR-200 and let-7 by natural agents leads to the reversal of epithelial-to-mesenchymal transition in gemcitabine-resistant pancreatic cancer cells.

Authors:  Yiwei Li; Timothy G VandenBoom; Dejuan Kong; Zhiwei Wang; Shadan Ali; Philip A Philip; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2009-08-04       Impact factor: 12.701

9.  MicroRNA regulates human vitamin D receptor.

Authors:  Takuya Mohri; Miki Nakajima; Shingo Takagi; Sayaka Komagata; Tsuyoshi Yokoi
Journal:  Int J Cancer       Date:  2009-09-15       Impact factor: 7.396

10.  A miRNA-regulatory network explains how dysregulated miRNAs perturb oncogenic processes across diverse cancers.

Authors:  Christopher L Plaisier; Min Pan; Nitin S Baliga
Journal:  Genome Res       Date:  2012-06-28       Impact factor: 9.043

View more
  13 in total

1.  MicroRNAs: New players in cancer prevention targeting Nrf2, oxidative stress and inflammatory pathways.

Authors:  Chengyue Zhang; Limin Shu; Ah-Ng Tony Kong
Journal:  Curr Pharmacol Rep       Date:  2015-01-11

2.  MiR-375 targets KLF4 and impacts the proliferation of colorectal carcinoma.

Authors:  Qiqi Mao; Tao Quan; Bin Luo; Xuefeng Guo; Lei Liu; Qinghui Zheng
Journal:  Tumour Biol       Date:  2015-07-30

3.  miR-122 inhibits cancer cell malignancy by targeting PKM2 in gallbladder carcinoma.

Authors:  Wei Lu; Yijian Zhang; Linzhu Zhou; Xuan Wang; Jiasheng Mu; Lin Jiang; Yunping Hu; Ping Dong; Yingbin Liu
Journal:  Tumour Biol       Date:  2015-11-06

4.  Sulindac Modulates the Response of Proficient MMR Colorectal Cancer to Anti-PD-L1 Immunotherapy.

Authors:  Bin Yi; Hao Cheng; Dorota Wyczechowska; Qingzhao Yu; Li Li; Augusto C Ochoa; Adam I Riker; Yaguang Xi
Journal:  Mol Cancer Ther       Date:  2021-04-20       Impact factor: 6.261

5.  MiR-200b expression in breast cancer: a prognostic marker and act on cell proliferation and apoptosis by targeting Sp1.

Authors:  YaSai Yao; Jian Hu; Zan Shen; RuYong Yao; ShiHai Liu; Yong Li; Hui Cong; XinGang Wang; WenSheng Qiu; Lu Yue
Journal:  J Cell Mol Med       Date:  2015-01-30       Impact factor: 5.310

6.  Silencing of miRNA-148a by hypermethylation activates the integrin-mediated signaling pathway in nasopharyngeal carcinoma.

Authors:  Hsin-Pai Li; Hsin-Yi Huang; Yi-Ru Lai; Jing-Xuan Huang; Kai-Ping Chang; Chuen Hsueh; Yu-Sun Chang
Journal:  Oncotarget       Date:  2014-09-15

7.  RUNX3 regulates renal cell carcinoma metastasis via targeting miR-6780a-5p/E-cadherin/EMT signaling axis.

Authors:  Feifei Chen; Xin Liu; Qian Cheng; Shudong Zhu; Jin Bai; Junnian Zheng
Journal:  Oncotarget       Date:  2017-11-08

Review 8.  New concepts and challenges in the clinical translation of cancer preventive therapies: the role of pharmacodynamic biomarkers.

Authors:  Karen Brown; Alessandro Rufini
Journal:  Ecancermedicalscience       Date:  2015-11-24

9.  Inhibition of breast cancer cell motility with a non-cyclooxygenase inhibitory derivative of sulindac by suppressing TGFβ/miR-21 signaling.

Authors:  Bin Yi; Hong Chang; Ruixia Ma; Xiangling Feng; Wei Li; Gary A Piazza; Yaguang Xi
Journal:  Oncotarget       Date:  2016-02-16

10.  miRNA-411 acts as a potential tumor suppressor miRNA via the downregulation of specificity protein 1 in breast cancer.

Authors:  Liangfeng Guo; Jianhui Yuan; Ni Xie; Huisheng Wu; Weicai Chen; Shufen Song; Xianming Wang
Journal:  Mol Med Rep       Date:  2016-08-19       Impact factor: 2.952

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.